Management of positive margins after total prostatectomy for localized prostate cancer;Prise en charge des marges positives après prostatectomie totale pour cancer localisé de la prostate

Progres en Urologie

Volumn 16, Issue 3, 2006, Pages 286-291

  Staerman, Frédéric ^a   Soulié, Michel ^b   Tostain, Jacques ^c   De Fromont, Marc ^d   Davin, Jean Louis ^e   Coulange, Christian ^f  

^a SERVICE DE DERMATOLOGIE   (France)

^b CHU RANGUEIL   (France)

^c HÔPITAL NORD   (France)

^d Prado Pathologie   (France)

^e Clinique Rhone Durance   (France)

^f Child and Adolescent Psychopathology Unit Salvator Hospital Public Assistance Marseille Hospitals University Aix Marseille II   (France)

Author keywords

Localized prostate cancer; Positive surgical margins; Total prostatectomy

Indexed keywords

HUMAN; MALE; PATHOLOGY; PROSTATE TUMOR; PROSTATECTOMY; REVIEW;

HUMANS; MALE; PROSTATECTOMY; PROSTATIC NEOPLASMS;

EID: 33748051424     PISSN: 11667087     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (38)

1. CATALONA W.J., BIGG S.W.: Nerve-sparing radical prostatectomy: evaluation of results after 250 patients. J. Urol., 1990; 143: 538-543.
2. EPSTEIN J.I.: Incidence and significance of positive margins in radical prostatectomy specimens. Urol. Clin. North Am., 1996; 23: 651-653.
3. HAN M., PARTIN A.W., CHAN D.Y., WALSH P.C.: An evaluation of the decreasing incidence of positive surgical margins in a large retro pubic prostatectomy series. J. Urol., 2004; 171: 23-26.
4. WIEDER J.A., SOLOWAY M.S.: Incidence, etiology, location, prevention and treatment of positive surgical margins after radical prostatectomy for prostate cancer. J. Urol., 1998; 160: 299-315.
5. BOLLA M., VAN POPPEL H., COLLETTE L., VAN CANGH P., VEKERMANS K., DA POZZO L., DE REIJKE T.M., VERBAEYS A., BOSSET J.F., VAN VELTHOVEN R., MARECHAL J.M., SCALLIET P., HAUSTERMANS K., PIERART M.: European Organization for Research and Treatment of Cancer: Postoperative radiotherapy after radical prostatectomy: a randomized controlled trial (EORTC trial 22911). Lancet, 2005; 366: 572-578.
6. GROSSFELD G.D., CHANG J.J., BROERING J.M., MILLER D.P., YU J., FLANDERS S.C., HENNING J.M., STIER D.M., CARROLL P.R.: Impact of positive surgical margins on prostate cancer recurrence and the use of secondary cancer treatment: data from the capsure database. J. Urol., 2000; 163: 1171-1177.
7. KAMAT A.M., BABAIAN K., CHEUING M.R., NAYA Y., HUANG S.H., KUBAN D., BABAIAN R.J.: Identification of factors predicting response to adjuvant radiation therapy in patients with positive margins after radical prostatectomy. J. Urol., 2003; 170: 1860-1869.
8. KATZ R., SALOMON L., HOZNEK A., de la TAILLE A., ANTIPHON P., ABBOU C.C.: Positive surgical margins in laparoscopic radical prostatectomy: the impact of apical dissection, bladder neck remodeling and nerve preservation. J. Urol., 2003; 169: 2049-2052.
9. D'AMICO A.V., WHITTIGTON R., MALKOWICZ S.B.: A multivariate analysis of clinical and pathological factors that predict for prostate specific antigen failure after radical prostatectomy for prostate cancer. J. Urol., 1995; 154: 131-138.
10. HAN M., PARTIN A.W., ZAHURAK M., PIANTADOSI S., EPSTEIN J.I., WALSH P.C.: Biochemical (prostate specific antigen) recurrence probability following radical prostatectomy for clinically localized prostate cancer. J. Urol., 2003; 169: 517-523.
11. ANSCHER M.S.: Adjuvant radiotherapy following radical prostatectomy is more effective and less toxic and salvage radiotherapy for a rising prostate specific antigen. Int. J. Cancer, 2001; 96: 91-93.
12. CHAWLA A.K., THAKRAL H.K., ZIETMAN A.L., SHIPLEY W.U.: Salvage radiotherapy after radical prostatectomy for prostate adenocarcinoma: analysis of efficacy and pronostic factors. Urology, 2002; 59: 726-731.
13. FORMAN J.D., VELASCO J.: Therapeutic radiation in patients with a rising post-prostatectomy PSA level. Oncology, 1998; 12: 33-47.
14. LIAUW S.L., WEBSTER W.S., PISTENMAA D.A., ROEHRBORN C.G.: Salvage radiotherapy for biochemical failure of radical prostatectomy: a single-institution experience. Urology, 2003; 61: 1204-1210.
15. McDONALD O.K., SCHILD S.E., VORA S.A., ANDREWS P.E., FERRIGNI R.G., NOVICKI D.E., SWANSON S.K., WONG W.W.: Radiotherapy for men with isolated increase in serum prostate specific antigen after radical prostatectomy. J. Urol., 2003; 170: 1833-1837.
16. OHORI M., WHEELER T.M., KATTAN M.W., GOTO Y., SCARDINO P.T.: Pronostic significance of positive surgical margins in radical prostatectomy specimens. J. Urol., 1995; 1818-1824.
17. EASTHAM J.A., KATTAN M.W., RIEDEL E., BEGG C.B., WHEELER T.M., GERICK C., GONEN M., REUTER V., SCARDINO P.: Variations among individual surgeons in the rate of positive surgical margins in radical prostatectomy specimens. J. Urol., 2003; 170: 2292-2295.
18. PETTUS J.A., WEIGHT C.J., THOMPSON C.J., MIDDLETON R.G., STEPHENSON R.A.: Biochemical failure in men following radical retropubic prostatectomy: impact of surgical margin status and location. J. Urol., 2004; 172: 129-132.
19. ALSIKAFI N.F., BRENDLER C.B.: Surgical modifications of radical retropubic prostatectomy to decrease incidence of positive surgical margins. J. Urol., 1998; 159: 1281-1285
20. SOULIE M., SEGUIN P., BENOIT J.M., ESCOURROU G., TOLLON C., VAZZOLER N., PONTONNIER F., PLANTE P.: Impact of a modified apical dissection during radical retropubic prostatectomy on the occurrence of positive surgical margins: a comparative study in 212 patients. Urology, 2001; 58: 217-221.
21. SALOMON L., ANASTASIADIS A.G., LEVREL O., KATZ R., SAINT F., DE LA TAILLE A., CICCO A., VORDOS D., HOZNEK A., CHOPIN D.K., ABBOU C.C.: Location of positive surgical margins after retropubic, perineal and laparoscopic radical prostatectomy for organ-confined prostate cancer. Urology, 2003; 61: 386-390.
22. PALISAAR R.J., NOLDUS J., GRAEFEN M., EBERSDOBLER A., HAESE A., HULAND H.: Influence of nerve-sparing procedure during radical prostatectomy on margins status and biochemical failure. Eur. Urol., 2005; 47: 176-184.
23. SOULIE M., BARRE C., BEUZEBOC P., CHAUTARD D., CORNUD F., ESCHWEGE P., FONTAINE E., MOLINIE V., MOREAU J.L., PENEAU M., RAVERY V., REBILLARD X., RICHAUD P., RUFFION A., SALOMON L., STAERMAN F., VILLERS A. Cancer de la prostate. Recommandations CCAFU 2004. Prog. Urol., 2004; 14: 913-955.
24. OHORI M., ABBAS F., WHELLER T.M., KATTAN M.W., SCARDINO P.T., LERNER S.P.: Pathological features and prognostic significance of prostate cancer in the apical section determined by whole mount histology. J. Urol., 1999; 161: 500-504.
25. PALISAAR R.J., GRAEFEN M., KARAKIEWICZ P.I., HAMMERER P.G., HULAND E., HAESE A., FERNANDEZ S., EBERSDOBLER A., HENKE R.P., HULAND H.: Assessment of clinical and pathological characteristics predisposing to disease recurrence following radical prostatectomy in men with pathologically organ-confined prostate cancer. Eur. Urol., 2002; 41: 155-161.
26. BARRE C., CHAUVEAU P., AILLET G., POCHOLLE P., COLLS P.: Etude des marges d'exérèses positives dans la prostatectomie radicale rétropubienne avec préservation nerveuse. Prog. Urol., 2003; 13: 47A.
27. PARTIN A.W., BORLAND R.N., EPSTEIN J.I., BRENDLER C.B.: Influence of wide excision of the neurovascular bundle(s) on prognosis in men with clinically localized prostate cancer with established capsular penetration. J. Urol., 1993; 150: 142-148.
28. SOULIE M., AZIZA R., ESCOURROU G., SEGUIN P., TOLLON C., MOLINIER L., BACHAUD J., JOFFRE F., PLANTE P.: Assessment of the risk of positive surgical margins with pelvi phased-array magnetic resonance imaging in patients with clinically localized prostate cancer: a prospective study. Urology, 2001; 58: 228-232.
29. OBEK C., SADEK S., LAI S., CIVANTOS F., RUBINOWICZ D., SOLOWAY M.S.: Positive surgical margins with radical retropubic prostatectomy: anatomic site-specific pathologic analysis and impact on prognosis. Urology, 1999; 54: 682-688.
30. SMITH R.C., PARTIN A.W., EPSTEIN J.I., BRENDLER C.B.: Extended followup of the influence of wide excision of the neurovascular bundle(s) on prognosis in men with clinically localized prostate cancer and extensive capsular perforation. J. Urol., 1996; 156: 454-457.
31. MAY F., TREUMANN T., DETTMAR P., HARTUNG R., BREUL J.: Limited value of endorectal magnetic resonance imaging and transrectal ultrasonography in the staging of clinically localized prostate cancer. BJU Int., 2001; 87: 66-69.
32. CHENG L., DARSON M.F., BERSGTRALH E.J., SLEZAK J., MYERS R.P., BOSTWICK D.G.: Correlation of margins status and extraprostatic extension with progression of prostate carcinoma. Cancer, 1999; 86: 1775-1782.
33. LEIBOVICH B.C., ENGEN D.E., PATTERSON D.E., PISANSKY T.M., ALEXANDER E.E., BLUTE M.L., BERGSTRALH E.J., ZINCKE H.: Benefit of adjuvant radiation therapy for localized prostate cancer with a positive surgical margin. J. Urol., 2000; 163: 1178-1182.
34. SCHILD S.E., PISANSKY T.M.: The role of radiotherapy after radical prostatectomy. Urol. Clin. North Am., 2001; 28: 629-637.
35. VALICENTI R.K., GOMELLA L.G., ISMAIL M., STRUP S.E., MULHOLLAND S.G., DICKER A.P., PETERSON R.O., NEWSCHAFFER C.J.: The efficacy of early adjuvant radiation therapy for pT3 N0 prostate cancer: a matched-pair analysis. Int. J. Radiat. Oncol. Biol. Phys., 1999; 45: 53-58.
36. SONG D.Y., THOMPSON T.L., RAMAKRISHNAN V., HARRISON R., BHAVSAR N., ONAODOWAN O., DEWEESE T.L.: Salvage radiotherapy for rising or persistent PSA after radical prostatectomy. Urology, 2002; 60: 281-287.
37. WIRTH M.P., SEE W.A., McLEOD D.G., IVERSEN P., MORRIS T., CARROLL K., Casodex Early Prostate Cancer Trialists' Group.: Bicalutamide 150 mg in addition to standard care in patients with localized or locally advanced prostate cancer: results from the second analysis of the early prostate cancer program at median followup of 5.4 years. J. Urol., 2004; 172: 1865-1870.
38. BEGG C.B., RIEDEL E.R., BACH P.B., KATTAN M.W., SCHRAG D., WARREN J.L., P.T. SCARDINO.: Variations in morbidity after radical prostatectomy. N. Engl. J. Med., 2002; 346: 1138-1144.